Effects of HAART on hepatitis C, hepatitis G, and TT virus in multiply coinfected HIV-positive patients with haemophilia (Q43036596)

12 November 2017

Effects of HAART on hepatitis C, hepatitis G, and TT virus in multiply coinfected HIV-positive patients with haemophilia (English)

1 reference

12 November 2017

0 references

Takamatsu J

1

1 reference

12 November 2017

Toyoda H

2

1 reference

12 November 2017

Fukuda Y

3

1 reference

12 November 2017

Nakano I

4

1 reference

12 November 2017

Yokozaki S

5

1 reference

12 November 2017

Hayashi K

6

1 reference

12 November 2017

Saito H

7

1 reference

12 November 2017

1 November 2001

1 reference

12 November 2017

1 reference

12 November 2017

7

1 reference

12 November 2017

575-581

1 reference

12 November 2017

6

1 reference

Descriptive epidemiology of HIV/AIDS in Japan, 1985-1994.

12 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Isolation of novel virus-like sequences associated with human hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Alphabet of hepatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

The acronym TTV. Transfusion transmitted virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Molecular investigation of GB virus C infection in hemophiliacs in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Prevalence and persistence of a novel DNA TT virus (TTV) infection in Japanese haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Infection with TT virus, a novel transfusion-transmissible DNA virus, in haemophiliacs and in blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Antiretroviral drugs for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Sequence heterogeneity within the 5'-terminal region of the hepatitis GB virus C genome and evidence for genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Possible association between serum GB virus C RNA level and disease activity in fulminant hepatitis type G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Detection of antibodies to a putative hepatitis G virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

An ELISA for detection of antibodies to the E2 protein of GB virus C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Clearance of hepatitis G viremia in a human immunodeficiency virus-positive patient by high-activity antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Mutation rate of GB virus C/hepatitis G virus over the entire genome and in subgenomic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Influence of HIV-1 infection on GBV-C infection in multiply infected haemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Global distribution of transfusion-transmitted virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

Prevalence of infection with TT virus (TTV), a novel DNA virus, in healthy Japanese subjects, newborn infants, cord blood and breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00567.X

10.1046/J.1365-2516.2001.00567.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference